rhinitis%20-%20allergic
RHINITIS - ALLERGIC
Allergic rhinitis is a symptomatic disorder of the nose secondary to IgE-mediated inflammation of the nasal membranes induced after exposure to allergens.
Major symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Other symptoms include headache, conjunctival symptoms, eye pruritus, impaired smell and morning cough.
Symptoms can reverse spontaneously with or without treatment.

Rhinitis - Allergic Drug Information

Drug Information
Acarizax
dermatophagoides farinae allergen extract + dermat...

Indication: House dust mite allergic asthma not well controlled by inhaled corticosteroids & associated w/ mild to sev...

Indication: Symptomatic treatment of seasonal & perennial allergic rhinitis.

Indication: Bronchial asthma. Respules: Acute laryngotracheobronchitis (croup) in infants & childn.

Indication: Regular treatment of asthma where use of combination (inhaled corticosteroid & long-acting β2

Indication: Regular treatment of asthma where use of combination (inhaled corticosteroid & long-acting β2

Indication: Symptomatic relief of nasal & nasopharyngeal congestion. Facilitates intranasal exam or before nasal surge...

Indication: Bronchodilator for maintenance treatment of bronchospasm associated w/ COPD including chronic bronchitis &...

Indication: Bronchodilator for maintenance treatment of bronchospasm, associated w/ COPD, including chronic bronchitis, em...

Indication: Bronchodilator for the prevention & treatment of symptoms in chronic obstructive airway disorders w/ rever...

Indication: Bronchodilator for the prevention & treatment of symptoms in chronic obstructive airway disorders w/ rever...

1  /  21
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 28 Apr 2020

Representatives from five Asian countries shared local experiences and current protocols for pharmacotherapy in treating patients with COVID-19 at a recent Asian Young Pharmacists' Group (AYPG) webinar.

Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 22 Sep 2020

Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.

Pearl Toh, 2 days ago
With much remains controversial regarding the possible transmission route of SARS-CoV-2 virus, a study reveals yet another surprise worthy of caution in the hospital setting.